ISOPTO CETAMIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Isopto Cetamide, and when can generic versions of Isopto Cetamide launch?
Isopto Cetamide is a drug marketed by Alcon and is included in one NDA.
The generic ingredient in ISOPTO CETAMIDE is sulfacetamide sodium. There are three drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Isopto Cetamide
A generic version of ISOPTO CETAMIDE was approved as sulfacetamide sodium by SANDOZ on October 18th, 1988.
Summary for ISOPTO CETAMIDE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 117 |
Patent Applications: | 4,076 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ISOPTO CETAMIDE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ISOPTO CETAMIDE
US Patents and Regulatory Information for ISOPTO CETAMIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alcon | ISOPTO CETAMIDE | sulfacetamide sodium | SOLUTION/DROPS;OPHTHALMIC | 080020-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |